Literature DB >> 27921161

An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction.

Kari Bo1, Helena C Frawley2, Bernard T Haylen3, Yoram Abramov4, Fernando G Almeida5, Bary Berghmans6, Maria Bortolini5, Chantale Dumoulin7, Mario Gomes8, Doreen McClurg9, Jane Meijlink10, Elizabeth Shelly11, Emanuel Trabuco12, Carolina Walker13, Amanda Wells14.   

Abstract

INTRODUCTION AND HYPOTHESIS: There has been an increasing need for the terminology on the conservative management of female pelvic floor dysfunction to be collated in a clinically based consensus report.
METHODS: This Report combines the input of members and elected nominees of the Standardization and Terminology Committees of two International Organizations, the International Urogynecological Association (IUGA) and the International Continence Society (ICS), assisted at intervals by many external referees. An extensive process of nine rounds of internal and external review was developed to exhaustively examine each definition, with decision-making by collective opinion (consensus). Before opening up for comments on the webpages of ICS and IUGA, five experts from physiotherapy, neurology, urology, urogynecology, and nursing were invited to comment on the paper.
RESULTS: A Terminology Report on the conservative management of female pelvic floor dysfunction, encompassing over 200 separate definitions, has been developed. It is clinically based, with the most common symptoms, signs, assessments, diagnoses, and treatments defined. Clarity and ease of use have been key aims to make it interpretable by practitioners and trainees in all the different specialty groups involved in female pelvic floor dysfunction. Ongoing review is not only anticipated, but will be required to keep the document updated and as widely acceptable as possible.
CONCLUSION: A consensus-based terminology report for the conservative management of female pelvic floor dysfunction has been produced, aimed at being a significant aid to clinical practice and a stimulus for research.

Entities:  

Keywords:  Consensus; Conservative management; Female; Pelvic floor dysfunction; Terminology

Mesh:

Year:  2016        PMID: 27921161     DOI: 10.1007/s00192-016-3123-4

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  63 in total

Review 1.  Urge incontinence and detrusor instability.

Authors:  C F Jabs; S L Stanton
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2001

2.  The appearance of levator ani muscle abnormalities in magnetic resonance images after vaginal delivery.

Authors:  John O L DeLancey; Rohna Kearney; Queena Chou; Steven Speights; Shereen Binno
Journal:  Obstet Gynecol       Date:  2003-01       Impact factor: 7.661

3.  Sexual desire and the female sexual function index (FSFI): a sexual desire cutpoint for clinical interpretation of the FSFI in women with and without hypoactive sexual desire disorder.

Authors:  Eric P Gerstenberger; Raymond C Rosen; Jessica V Brewer; Cindy M Meston; Lori A Brotto; Markus Wiegel; Michael Sand
Journal:  J Sex Med       Date:  2010-09       Impact factor: 3.802

4.  The assessment of levator trauma: a comparison between palpation and 4D pelvic floor ultrasound.

Authors:  H P Dietz; G Hyland; J Hay-Smith
Journal:  Neurourol Urodyn       Date:  2006       Impact factor: 2.696

5.  Self-efficacy: toward a unifying theory of behavioral change.

Authors:  A Bandura
Journal:  Psychol Rev       Date:  1977-03       Impact factor: 8.934

6.  Recurrent urinary tract infection.

Authors:  Annette Epp; Annick Larochelle
Journal:  J Obstet Gynaecol Can       Date:  2010-11

7.  Levator ani defect scores and pelvic organ prolapse: is there a threshold effect?

Authors:  Mitchell B Berger; Daniel M Morgan; John O DeLancey
Journal:  Int Urogynecol J       Date:  2014-05-01       Impact factor: 2.894

8.  Patients' experiences of learning clean intermittent self-catheterization: a qualitative study.

Authors:  Karen Logan; Chris Shaw; Irene Webber; Sandra Samuel; Lynne Broome
Journal:  J Adv Nurs       Date:  2008-04       Impact factor: 3.187

Review 9.  Types of urethral catheters for management of short-term voiding problems in hospitalised adults.

Authors:  K Schumm; T B L Lam
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

Review 10.  Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP).

Authors:  Gillian A Hawker; Samra Mian; Tetyana Kendzerska; Melissa French
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

View more
  62 in total

1.  Narrative review of pelvic floor muscle training for childbearing women-why, when, what, and how.

Authors:  Stephanie J Woodley; E Jean C Hay-Smith
Journal:  Int Urogynecol J       Date:  2021-05-05       Impact factor: 2.894

Review 2.  Treatment of urinary incontinence: a critical appraisal of clinical practice guidelines with the AGREE II instrument.

Authors:  Flávia Blaseck Sorrilha; Lauren Giustti Mazzei; Luciane Cruz Lopes; Silvio Barberato-Filho; Juliana Castro; Analaura Castro; Claudia Marcela Vélez; Cristiane de Cássia Bergamaschi
Journal:  Int Urogynecol J       Date:  2021-03-11       Impact factor: 2.894

3.  Comment on the recently published IUGA/ICS joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction.

Authors:  Helena Talasz; Markus Kofler; Monika Lechleitner
Journal:  Int Urogynecol J       Date:  2017-03-02       Impact factor: 2.894

4.  Response to comment on the IUGA/ICS joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction.

Authors:  Kari Bo; Helena C Frawley; Bernard T Haylen; Melanie Morin; Elizabeth Shelly
Journal:  Int Urogynecol J       Date:  2017-06-15       Impact factor: 2.894

Review 5.  Advances in basic science methodologies for clinical diagnosis in female stress urinary incontinence.

Authors:  Marwa Abdulaziz; Emily G Deegan; Alex Kavanagh; Lynn Stothers; Denise Pugash; Andrew Macnab
Journal:  Can Urol Assoc J       Date:  2017-06       Impact factor: 1.862

6.  Health-related quality of life and pelvic floor dysfunction in advanced-stage ovarian cancer survivors: associations with objective activity behaviors and physiological characteristics.

Authors:  Christelle Schofield; Robert U Newton; Paul A Cohen; Daniel A Galvão; Joanne A McVeigh; Ganendra R Mohan; Jason Tan; Stuart G Salfinger; Leon M Straker; Carolyn J Peddle-McIntyre
Journal:  Support Care Cancer       Date:  2018-02-01       Impact factor: 3.603

7.  Pelvic floor muscle weakness: a risk factor for anterior vaginal wall prolapse recurrence.

Authors:  Jeffrey S Schachar; Hemikaa Devakumar; Laura Martin; Sara Farag; Eric A Hurtado; G Willy Davila
Journal:  Int Urogynecol J       Date:  2018-03-19       Impact factor: 2.894

8.  Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women: a cochrane systematic review abridged republication.

Authors:  Licia P Cacciari; Chantale Dumoulin; E Jean Hay-Smith
Journal:  Braz J Phys Ther       Date:  2019-01-22       Impact factor: 3.377

Review 9.  How to report electrotherapy parameters and procedures for pelvic floor dysfunction.

Authors:  Angélica Mércia Pascon Barbosa; Nivaldo Antonio Parizotto; Cristiane Rodrigues Pedroni; Mariana Arias Avila; Richard Eloin Liebano; Patricia Driusso
Journal:  Int Urogynecol J       Date:  2018-08-24       Impact factor: 2.894

10.  Comparison of inflammatory urine markers in patients with interstitial cystitis and overactive bladder.

Authors:  Akira Furuta; Tokunori Yamamoto; Yasuyuki Suzuki; Momokazu Gotoh; Shin Egawa; Naoki Yoshimura
Journal:  Int Urogynecol J       Date:  2018-01-25       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.